These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28749330)

  • 21. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
    Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
    BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M; Malhotra B; Khandelwal S
    Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
    Rindi L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Kim DH; Kim SY; Koh WJ; Jhun BW
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230620. PubMed ID: 33903101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.
    Tsukatani T; Suenaga H; Shiga M; Ikegami T; Ishiyama M; Ezoe T; Matsumoto K
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1965-73. PubMed ID: 26173690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trend of nontuberculous mycobacteria species and minimal inhibitory concentration in a referral laboratory in Korea from 2013 to 2019.
    Kim YJ; Kim S; Ham H; Yu S; Choo HJ; Kim HJ; Heo R; Choi G; Kim SH; Lee HJ
    J Infect Public Health; 2024 Feb; 17(2):212-216. PubMed ID: 38113818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of drug susceptibility in rapidly growing mycobacteria by resazurin broth microdilution assay.
    Castilho AL; Caleffi-Ferracioli KR; Canezin PH; Dias Siqueira VL; de Lima Scodro RB; Cardoso RF
    J Microbiol Methods; 2015 Apr; 111():119-21. PubMed ID: 25683207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and drug susceptibility testing for nontuberculous mycobacteria.
    Huang WC; Yu MC; Huang YW
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S32-S41. PubMed ID: 32423573
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Kim DH; Zo S; Kim SY; Jhun BW
    Ann Lab Med; 2024 Jan; 44(1):92-96. PubMed ID: 37665290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
    Sethiya JP; Sowards MA; Jackson M; North EJ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode.
    Marini E; Di Giulio M; Ginestra G; Magi G; Di Lodovico S; Marino A; Facinelli B; Cellini L; Nostro A
    PLoS One; 2019; 14(7):e0219038. PubMed ID: 31260476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivo.
    Ragunathan P; Sae-Lao P; Hamela C; Alcaraz M; Krah A; Poh WH; Ern Pee CJ; Hou Lim AY; Rice SA; Pethe K; Bond PJ; Dick T; Kremer L; Bates RW; Grüber G
    J Biol Chem; 2024 Feb; 300(2):105618. PubMed ID: 38176652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment.
    Pereira SG; Alarico S; Tiago I; Reis D; Nunes-Costa D; Cardoso O; Maranha A; Empadinhas N
    BMC Microbiol; 2019 Mar; 19(1):62. PubMed ID: 30890149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.